Clinical Trial Update: Assessment of Safety and Efficacy of SGLT2is Among LN Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updating safety and efficacy of SGLT2 inhibitors in lupus nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Snippet

Sponsor: Ain Shams University | Conditions: Lupus Nephritis | Phase 1, Phase 2 | Status: UNKNOWN